Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study
Study Overview The study aims to evaluate and compare the effectiveness of three treatments—ripertamab, rituximab, and efgartigimod—administered to patients diagnosed […]
